The latest policy and advocacy updates related to the field of clinical and translational science.
In mid-April, nearly 250 volunteer advocates participated in the Coalition for Clinical and Translational Sciences (CCTS) 2023 Capitol Hill Advocacy Day. Advocates represented 32 states, the District of Columbia, and Puerto Rico, and visited the offices of their House Representatives and U.S. Senators.
The CCTS advocacy visits were well-timed as Congress is currently making key decisions about Fiscal Year (FY) 2024 funding levels for federal medical research and public health programs. Moreover, there are dozens of new legislators in the House and Senate and the Hill Day was an excellent opportunity for elected officials to form local connections with the community while learning about the value and impact of the full spectrum of medical research. Specifically, CCTS advocates asked congressional offices to support the following community funding priorities:
The outreach was well received, and the House Labor-HHS-Education Appropriations Subcommittee even asked Acting NIH Director Dr. Larry Tabak a question about the significance of the Clinical and Translational Science Awards (CTSA) program during an FY 2024 budget hearing the following day. Dr. Tabak respond with a positive assessment of CTSAs and the networks contributions to community access and engagement and rural care.
(a portion of the group of CCTS advocates that traveled to Capitol Hill for the 2023 Advocacy Day).
By: Dane Christiansen, Washington Representative